Helping health innovations prove their value.
IS4Health is a specialist consultancy in HTA, HEOR, and market access for medtech, digital health, diagnostics, and other healthcare innovations.
We work with innovators who need robust evidence, clear strategy, and practical support to navigate reimbursement and health system decision-making.
Why IS4Health
A focused partner for health innovators
A focused partner for health innovators who need evidence, strategy, and access — delivered with clarity and rigour.
Tailored support
We provide customised support tailored to the specific needs, stage, and goals of each client and health technology.
Expertise across HTA and HEOR
Our work combines health technology assessment, health economics and outcomes research, reimbursement, and market access to support evidence-based decision-making.
Practical and flexible collaboration
We offer an agile and responsive way of working, with solutions designed to match the pace and priorities of startups, SMEs, and healthcare innovators.
International perspective
We support projects across different healthcare systems and reimbursement environments, with a focus on European market access pathways.
Evidence that supports adoption
We help clients generate, structure, and communicate the evidence needed to demonstrate value to payers, decision-makers, clinicians, and other stakeholders.
Services
What we do
End-to-end support across HTA, HEOR, reimbursement, and market access.
HTA Strategy
We support clients in developing HTA strategies that align with payer expectations, evidence requirements, and market access objectives.
HEOR Support
We provide health economics and outcomes research support to help demonstrate the clinical and economic value of health technologies.
Evidence Synthesis
We identify, assess, and synthesise clinical, economic, and real-world evidence to support decision-making and reimbursement.
Systematic Literature Reviews
We conduct structured literature reviews to identify and evaluate published evidence relevant to health technologies, outcomes, comparators, and target populations.
Cost-Effectiveness Modelling
We develop economic models to assess the value of health technologies in terms of costs, outcomes, and long-term impact.
Budget Impact Analysis
We estimate the potential financial consequences of adopting new technologies within healthcare systems and payer budgets.
Reimbursement Strategy
We help clients understand reimbursement requirements, identify evidence gaps, and prepare for payer discussions.
Market Access Planning
We support the development of market access strategies tailored to different healthcare systems, countries, and stakeholder expectations.
Value Dossier Development
We help prepare value dossiers and supporting materials that communicate the clinical, economic, and patient value of a technology.
Payer Evidence Preparation
We support the preparation of evidence packages, presentations, and materials for discussions with payers and other decision-makers.
Who we work with
Our clients and partners
We partner with organisations at every stage of the healthcare innovation journey.
Health Startups
We support early-stage and growing companies that need evidence, strategy, and market access planning to bring new technologies to healthcare systems.
MedTech Companies
We work with medical device companies to demonstrate clinical and economic value and prepare for reimbursement and adoption.
Digital Health Innovators
We support developers of digital therapeutics, AI-based tools, remote monitoring solutions, and other digital health technologies.
Diagnostics Companies
We help diagnostics developers build evidence for clinical utility, economic value, and reimbursement.
Pharmaceutical Companies
We provide support for evidence generation, HEOR, HTA, and reimbursement planning across different therapeutic areas.
Healthcare Providers and Hospitals
We support providers seeking to evaluate, adopt, and communicate the value of new technologies and care pathways.
Investors and Strategic Partners
We help investors, accelerators, and strategic partners better understand the evidence and market access potential of healthcare innovations.
About IS4Health
Clear evidence. Practical strategy. Real impact.
IS4Health is a specialist consultancy focused on HTA, HEOR, reimbursement, and market access for healthcare innovations.
We support companies and organisations that need clear evidence, strong value propositions, and practical strategies to navigate increasingly complex healthcare systems.
Our work combines evidence synthesis, economic evaluation, reimbursement planning, and stakeholder-focused communication to help health technologies demonstrate their value.
We work across medtech, digital health, diagnostics, AI-based technologies, and other healthcare innovations, with a particular focus on European healthcare systems and reimbursement environments.
IS4Health aims to provide flexible, responsive, and tailored support to clients ranging from early-stage startups to established healthcare companies.
Founder
Gábor Varga
Founder and Consultant
Gábor has experience in HTA, HEOR, evidence synthesis, reimbursement, and market access across a range of healthcare technologies and projects.
He has been actively involved in EU-funded projects supporting startups developing digital health platforms and applications, with a particular focus on evidence generation, value demonstration, and market access planning.
He has also supported healthcare startups through programmes funded by EIT Health, providing expertise in areas such as scoping reviews, evidence synthesis, and economic modelling.
His experience includes the development of global value dossiers, Markov models, cost-effectiveness analyses, budget impact models, and other HEOR tools used to support reimbursement and payer decision-making.
Gábor has worked across medical devices, digital health technologies, diagnostics, AI-based healthcare solutions, and other innovative health technologies.
Through IS4Health, he aims to help innovators build stronger evidence, communicate value more effectively, and make better-informed decisions about market access and reimbursement strategy.
Need support with HTA, HEOR, or market access?
Let's discuss how IS4Health can support your project.